The incidence of monozygotic twinning following PGD is not increased
|
|
- Tyler Francis
- 6 years ago
- Views:
Transcription
1 Human Reproduction, Vol.24, No.11 pp , 2009 Advanced Access publication on August 6, 2009 doi: /humrep/dep280 ORIGINAL ARTICLE Reproductive genetics The incidence of monozygotic twinning following PGD is not increased W. Verpoest 1,3, L. Van Landuyt 1, S. Desmyttere 2, A. Cremers 1, P. Devroey 1, and I. Liebaers 2 1 Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, 101 Laarbeeklaan, B-1090 Brussel, Belgium 2 Centre for Medical Genetics, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, 101 Laarbeeklaan, B-1090 Brussel, Belgium 3 Correspondence address. willem.verpoest@uzbrussel.be background: Monozygotic (MZ) twin pregnancies are associated with increased perinatal mortality and morbidity, and risk of congenital anomalies. The causes of MZ twinning in humans are unclear but the incidence may increase after PGD, for example, as a result of holes created in the zona pellucida. We compared the incidence of MZ twin pregnancies in ICSI cycles with PGD, versus ICSI cycles without PGD. methods: In this retrospective comparative cohort study, we analysed incidence of twin pregnancies in unselected patients undergoing ICSI and PGD (group A; 1992 cycles) with blastocyst transfer at Day 5, versus a period-matched control population of unselected patients undergoing ICSI and blastocyst transfer at Day 5 without PGD (group B; 2429 cycles) from January 2001 to December results: Clinical pregnancy per embryo transfer was established in 618/1992 (31.0%) and 947/2429 (39.0%) in group A versus B, respectively (P, 0.01). Overall MZ twin rate was 29/4421 (0.7%) per embryo transfer and 29/1565 (1.9%) per established clinical pregnancy. The incidence of MZ twinning per established clinical pregnancy did not differ between groups (1.5 versus 2.1%, group A and B, respectively). In group A, seven MZ twins were born versus 19 MZ twins in group B. In group B, one MZ twin pregnancy resulted in two stillbirths. In group A, two MZ twins had severe congenital malformations versus none in group B. conclusions: The incidence of MZ twinning was not increased in PGD compared with regular ICSI with blastocyst transfer. This information is useful in counselling patients about potential risks of PGD. Key words: monozygotic / twins / PGD / ICSI / blastocyst transfer Introduction Monozygotic (MZ) twinning occurs in 0.42% (Bulmer, 1970) to 0.45% (Derom et al., 1987; Costa, 2001) of spontaneous pregnancies. By definition MZ twins arise from one single zygote splitting into two separate individuals. The incidence is about one-third of spontaneously conceived twin pregnancies. The causes of MZ twinning in humans are not clear (Hershlag et al., 1999; Hall, 2003; Toledo, 2005). The incidence of MZ twin pregnancies in assisted reproduction treatment (ART) conceptions is higher compared with pregnancies after spontaneous conception. Figures of 0.72% in IVF and 0.86% in ICSI (Schachter et al., 2001), to as high as 8.9% (Abusheika et al., 2000) have been reported. The true incidence, however, is unknown owing to the use of proxy estimations (Blickstein, 2005). Factors which appear to influence MZ twinning are ovulation induction (Derom et al., 1987), embryo culture conditions (Edwards et al., 1986) and artificial breach of the zona pellucida, for instance ICSI and assisted hatching (AH) (Hershlag et al., 1999). Other reports describe a higher incidence of twinning, including MZ twinning, in pregnancies after transfer of blastocyst stage embryos, compared with pregnancies achieved after transfer of cleavage stage embryos (Edwards et al., 1986; Hall, 2003, 2005). Reports on the incidence of MZ twinning after the use of ART in combination with PGD and preimplantation genetic screening (PGS) are lacking. The incidence of MZ twin pregnancies in PGD is potentially increased as a result of different mechanisms, including breaks and intentional holes in the zona pellucida associated with handling, and more specifically with blastomere biopsy (Table I). MZ twin pregnancies are associated with a 3 5-fold higher perinatal mortality rate as compared with dizygotic (DZ) twins, and with up to seven times the risk of perinatal mortality as compared with singleton pregnancies (Derom et al., 1987; Malone, 2003; Toledo, 2005). MZ twins are at greater risk of perinatal morbidity associated with premature and preterm birth than DZ twins (Sebire et al., 1997). Up to 30% of monochorionic diamniotic (MCDA) twin pregnancies are associated with twin-to-twin transfusion syndrome (TTTS). TTTS is associated with severe neurological damage and accounts for 15% of the perinatal mortality in MCDA twins (Machin, 2004). In MZ twins, congenital & The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please journals.permissions@oxfordjournals.org
2 2946 Verpoest et al. Table I Factors associated with MZ twinning Intrinsic factors Extrinsic factors... Age Artificial breach of zona pellucida Hardening of zona pellucida ICSI Irregular zona pellucida thickness Hatching Embryo biopsy Schachter et al. (2001), Toledo (2005) Hershlag et al. (1999), Abusheika et al. (2000), Saito et al. (2000), Schieve et al. (2000), Tarlatzis et al. (2002), Toledo (2005) Skewed X chromosome inactivation (explaining excess of female MZ twins) Burn and Corney (1988), Chitnis et al. (1999), Healey et al. (2001) Inherited defects in zona pellucida proteins Fragile zona pellucida that allows early separation of clumps of blastocysts Failure or delay of cell-to-cell recognition and adhesion Shapiro et al. (1978), Healey et al. (2001) Transfer of Day 5 blastocyst stage embryos compared with transfer of Day 3 cleavage stage embryos Behr et al. (2000), Hall (2003), Milki et al. (2003), Jain et al. (2004), Wright et al. (2004), Chang et al. (2009) Embryo culture conditions (culture media and time) Hardening of zona pellucida Apoptosis with changes in inner cell mass Edwards et al. (1986), Derom et al. (1987); Abusheika et al. (2000), Behr et al. (2000), Schachter et al. (2001), Menezo and Sakkas (2002), Cassuto et al. (2003), Milki et al. (2003), Toledo (2005) Cyclic oestrus type of reproduction Fractured zona pellucida as a consequence of fertilization of an old ovum Medication-induced structural alterations of zona pellucida Ovulation induction with gonadotrophins or clomiphene citrate Hall (2003) Derom et al. (1987), Hall (2001), Schachter et al. (2001), Toledo (2005) anomalies occur frequently both in live born babies and miscarriages. They may include congenital abnormalities such as cloacal anomalies, neural-tube-defects and congenital heart defects, disruptions such as limb reduction defects and amyoplasia related to shared placental circulation, as well as deformations associated with constraint and intrauterine crowding e.g. clubfeet, dislocated hips and craniosynostosis. The risk of congenital anomalies in MZ twins is 2 3-fold that of singleton neonates, with an estimated incidence of 10% (Hall, 2003). The aim of this study was to assess the incidence of MZ twin pregnancies in a large cohort of consecutive PGD treatment cycles, in comparison with a period-matched cohort of consecutive ICSI cycles with blastocyst transfer at the same centre. Materials and Methods In this retrospective cohort study, we analysed the incidence of MZ twin pregnancies in a cohort of consecutive treatment cycles of ICSI combined with PGD and blastocyst transfer (group A), and compared the results with a control cohort of consecutive cycles of ICSI and blastocyst transfer without PGD (group B). The study was conducted at a large tertiary referral centre for reproductive medicine and PGD, and included data from January 2001 to December There were no differences in laboratory conditions or clinical procedures between group A and B, except for the biopsy procedure for PGD in group A. The details of the ICSI procedure have been described previously (Van Landuyt et al., 2005). In group A (PGD/PGS), ICSI was performed rather than classical IVF to prevent contamination with residual sperm DNA in case of PCR-based PGD (Liebaers et al., 1998) and to maximize the fertilization rate in PGS. AH was never used. Fertilization was assessed h after ICSI. Further development was evaluated in the morning of Day 2 and again on Day 3, when embryos were evaluated before biopsy. Different blastocyst culture media were used over the years studied [Medicult w Blastassist w system (Jyllinge, Denmark); Vitrolife w G2 w and G3 w series (Goteborg, Sweden); Cook medical w Sydney IVF w media (Limerick, Ireland)]. There was however, no difference in culture medium used between group A and group B. According to the number of anucleate fragments, the embryos were subdivided into grades A, B, C and D as described previously (Vandervorst et al., 1998). From the 5-cell stage onwards for fluorescence in-situ hybridization (FISH) analysis and from the 6-cell stage onwards biopsy of grades A, B and C embryos were performed on Day 3 of culture. Laser-assisted biopsy was applied consistently as previously described (De Vos and Van Steirteghem, 2001; Sermon, 2002). Overall the aspiration method was used to remove one or two blastomeres from the embryo. For PCR analysis, each blastomere was placed in a solution that lyses the cell and releases the DNA (Sermon et al., 2004). For FISH purposes, a blastomere was spread on a slide using the HCl/Tween 20 method (Coonen et al., 1994). The PCR procedures were performed as previously described (Sermon et al., 2001; Sermon and De Rycke, 2007). At our centre, multiplex PCR was the standard method of DNA amplification at single cell level, reducing both the risk of undetected contamination and allele drop out by the use of linked markers alone, or linked markers combined with the detection of a specific mutation (Sermon, 2002). Numerical chromosomal analysis was performed using a FISH procedure, allowing analysis of chromosomes X, Y, 13, 18 and 21, and chromosomes 16 and 22 in a second round of hybridization (Staessen et al., 1999, 2004). For reciprocal translocations, the direct labelled and commercially available probes (from Vysis or Cytocell) consisted of a combination of three probes, one telomeric and two centromeric, or two
3 No increase in monozygotic twinning with PGD 2947 telomeric and one centromeric of the chromosomes involved. For Robertsonian translocations, we used a combination of either two subtelomeric or two locus-specific probes or a combination of a subtelomeric and a locus-specific probe. By this approach, the embryos carrying normal or balanced chromosomes can be differentiated from the embryos carrying unbalanced chromosomes. One or more unaffected embryos were transferred into the uterus on Day 5 post insemination, in group A as well as in group B subject to availability and (legal) restrictions on the number of embryos for transfer. As in regular IVF cycles, the age of the female partner, the rank of trial and embryo quality determined the number of embryos transferred. For Belgian patients, the number of embryos for transfer was restricted according to age and rules laid out by federal law from July 2003 onwards (Van Landuyt et al., 2006). Supernumerary unaffected embryos were cryopreserved subject to consent by the couple. A clinical pregnancy was defined as one or more gestational sacs seen at transvaginal ultrasound scan at least 5 weeks after embryo transfer. MZ twins were identified at first ultrasound when the number of fetal heartbeats exceeded the number of gestational sacs, or when the number of sacs exceeded the number of embryos transferred. Chorionicity of the twin pregnancy was routinely determined by transvaginal ultrasound at 7 weeks of gestation, and was confirmed by a second ultrasound scan between 2 and 5 weeks following the initial ultrasound. The monochorionicity at ultrasound was used as a confirmation of the monozygotic status of the pregnancy following blastocyst transfer. Evidence of division of inner cell mass (ICM) on blastocyst examination on Day 5 was not observed and not used as a criterion to diagnose a MZ pregnancy. The data on treatment characteristics and outcome were recorded by a dedicated team of embryologists, nurses and physicians. Student s unpaired t-test and x 2 -test were used to assess differences in continuous and categorical variables, respectively. P-values of,0.05 were considered statistically significant. Results The mean patient age at conception was 33.9 (SD +4.7) years in group A versus 31.9 (SD +4.7) years in group B (P, 0.01). In group A, 1297 patients underwent 1992 PGD blastocyst transfers while in group B 1786 patients underwent 2429 blastocyst transfers. The mean number of embryos transferred in both groups was 1.6. Clinical pregnancy per embryo transfer was established in 618/1992 (31.0%) in group A and in 947/2429 (39.0%) in group B (P, 0.01) (Table II). The overall (group AþB) MZ twin rate was 29/4421 (0.7%) per embryo transfer and 29/1565 (1.9%) per established clinical pregnancy. In group A, four MZ twins pregnancies were identified solely by determination of chorionicity at ultrasound on the basis that the number of blastocysts transferred was equal to or higher than the number of gestational sacs observed; five MZ twin pregnancies were identified on the basis of gestational sacs at ultrasound being supernumerary to the number of embryos transferred. In group B 10 MZ twin pregnancies were identified solely by determination of chorionicity at ultrasound, versus 10 on the basis of supernumerary gestational sacs. Despite the secular trends in use of culture media, no culture media-related or time-related changes in incidence of MZ twinning were observed during the time period studied. Per established clinical pregnancy in group A, nine MZ twin pregnancies were observed (1.5%). Of these, three pregnancies ended in miscarriage, one in selective termination of the twin pregnancy (triplet pregnancy reduced to singleton) and in three pregnancies Table II Analysis of twin pregnancies in patients undergoing ICSI and PGD (group A) with blastocyst transfer at Day 5, versus controls undergoing ICSI and blastocyst transfer at Day 5 without PGD (group B) Group A Group B... # patients Mean age (years) P, 0.01 # embryo transfers Mean # embryos NS transferred Clinical pregnancy rate per transfer one twin showed arrested development in the first trimester of pregnancy (vanished twin). In group B, 20 MZ twin pregnancies were observed (2.1%) (versus 1.5% in group A, not significant). Of these, four pregnancies resulted in a miscarriage, six in selective termination of the twin pregnancy (triplet pregnancy reduced to singleton) and one pregnancy showed a vanished twin. One set of MZ twins (11%) was identified as monochorionic monoamniotic (MCMA) in group A, versus four MCMA twins (20%) in group B. In group A seven MZ twins have been born at a mean gestational age of 35.5 weeks (SD +2.5) and a mean birthweight of 2628 g (SD +487) versus 19 MZ twins in group B with a mean gestational age of 35.3 weeks (SD +3.4) and mean birthweight of 2301 g (SD +691). In group B one MZ twin pregnancy resulted in stillbirth of both siblings secondary to premature prelabour rupture of membranes at 20 weeks and 6 days of gestation. In group A two MZ twins were born with severe congenital malformations versus none in group B. The severe congenital abnormalities consisted of unilateral left-sided testicular atrophy in sibling twins born at a gestation of 34 weeks and 5 days (Table II). Discussion 618/1992 (31%) 947/2429 (39%) # MZ twin pregnancies 9 (1.5%) 20 (2.1%) NS # MZ twins born 7 19 Mean gestational age (weeks) Mean birthweight (g) Stillbirth 0 2 Siblings # offspring with congenital anomalies 2 0 P, 0.01 This study shows that the incidence of MZ twin pregnancies is not increased as a result of the embryo biopsy procedure for PGD. Despite weaknesses in terms of limited sample size and retrospective analysis, the data presented in this study will inevitably contribute to the knowledge on this topic, as reports on the incidence of MZ twinning in PGD are lacking. The incidence of predominantly dichorionic twins in ART is evidently increased as a result of the transfer of multiple embryos in a lot of cases. The incidence of MZ twins, however, has also been reported to be increased 2 4-fold in ART (Cohen et al., 1992; Costa et al., 2001). MZ twinning has previously been shown to be
4 2948 Verpoest et al. unrelated to maternal age, paternal age, gonadotrophin dosage, peak estradiol and progesterone levels, number of oocytes collected and number of embryos transferred (Alikani et al., 2003); whereas some have argued a causal relationship between the higher number of embryos transferred and MZ twinning (Scott Sills et al., 2000). In general, DNA analysis is the Gold Standard for determining MZ status but was not performed routinely in our cohort of MZ twins, as is the case in most studies on MZ twins (Blickstein, 2005). The most frequently used estimation of monozygosity counts the number of monochorionic twins, either by antenatal sonography or by post-partum placental examination. However, several limitations must be taken into consideration. Despite the current developments in ultrasonographic equipment that generally allow very accurate determination of chorionic and amniotic types in multifetal pregnancies at first trimester ultrasound (Monteagudo et al., 1994), limited access to this equipment or inappropriate or untimely application may lead to inaccuracies. First, the incidence of MZ twins may generally be overreported if implantation of the placentas was so close that no distinction could be made. In association with same sex and lack of documentation of the intertwin membrane, which helps in identifying the chorionicity, zygosity [MZ or DZ] may not be determined (Bulmer, 1970). Second, zygosity remains unknown in all like-sex dichorionic twins: estimates of MZ twinning based on chorionicity and fetal sex will miss the MZ dichorionic twins and therefore underestimate the true incidence of MZ twins. And last, also the number of gestational sacs in excess of or equal to the number of transferred embryos may underestimate the frequency of MZ twins because of the inability to differentiate like-sex dichorionic DZ from dichorionic MZ twins. One of the strengths of this study was to only include cycles with blastocyst transfer at Day 5. In the understanding that MZ twins arising in the first 4 days of embryonic development are dichorionic diamniotic and that these would have been picked up on embryological analysis in the lab prior to blastocyst transfer at Day 5, all monochorionic twin pregnancies in our study are to be defined as MZ, thereby avoiding the aforementioned potential biases in MZ twin identification (Tarlatzis et al., 2002; Blickstein, 2005). On the other hand, the true incidence of MZ twins is underestimated in our study owing to the inability to differentiate like-sex dichorionic DZ twins from dichorionic MZ twins following arrested development of one of two transferred embryos (Scott Sills et al., 2000; Blickstein, 2005) and because there is no confirmation by DNA analysis of monozygosity. Most published reports have used the same criteria for identifying MZ twin pregnancies, i.e. without post-natal DNA analysis being available (Frankfurter et al., 2004; Wright et al., 2004). Potential mechanisms that may increase the incidence of MZ twins both in IVF/ICSI and PGD are given in Table I. They include breaks in the zona pellucida associated with handling, and especially the creation of intentional holes e.g. by ICSI or embryo biopsy for PGD. The technique for breaching the zona pellucida by laser in order to perform embryo biopsy for PGD is to some degree analogous with that used for AH. This technique has been advocated in patients with poor embryonic characteristics or implantation failure, and is aimed at improving implantation by facilitating the hatching process by creating a hole in the zona pellucida or by zona thinning (Alikani et al., 2003). The opinion about the role of hatching in the etiology of MZ twins in assisted reproduction is divided. By performing AH, the overall multiple pregnancy rates per embryo transfer increases from 6.8 to 13.1% (Hershlag et al., 1999). In one study, the rate of MZ twinning was significantly increased in the hatched series to 1.2% per embryo transfer. A possible explanation is that a zona opening, sometimes too narrow, could lead to splitting of the ICM (Hershlag et al., 1999). In another study AH, in combination with patient and embryo conditions that justified embryo hatching, was shown to increase the risk for MZ twinning significantly (Alikani et al., 2003). Scott Sills et al. (2000) on the other hand suggest that the causal relationship between AH and MZ twinning is highly speculative: among IVF study patients they found that the frequency of MZ twinning was not significantly different between zona manipulated and zona intact subgroups, and they think it may be premature to link MZ twinning and AH. The greater overall frequency of MZ twinning for IVF patients could result from the higher number of embryos transferred in IVF, rather than zona manipulations. They also argue that blastocoeles have never been observed to divide after passing through an artificial zona opening. Also, MZ twin evolution as well as natural blastocyst hatching in humans is incompletely characterized; what is known has been extrapolated from animal models (Scott Sills et al., 2000). Other studies have not been able to establish a relationship between zona breaching techniques and MZ twinning either (Blickstein et al., 1999; Schachter et al., 2001; Milki et al., 2003). An inducing effect of prolonged embryo culture on the incidence of MZ twinning was suggested before by Edwards et al. (1986) and was later proposed by other authors (Behr et al., 2000). Splitting of the ICM may be induced by perturbations of cell-to-cell adhesion. Also the use of specific culture media can be associated with the appearance of MZ twinning (Behr et al., 2000; Menezo and Sakkas, 2002). A number of hypotheses have been proposed. In vitro related zona hardening as a result of prolonged culture may induce division of embryos into two during (assisted) hatching (Alikani et al., 1994). Another hypothesis presumes a possible anomaly in the distribution of the ICM cells as a consequence of sensitivity to culture media containing an excessive glucose level. The ICM cells appear more sensitive to apoptosis than trophoblastic cells (Menezo and Sakkas, 2002). The presence of congenital anomalies in one set of sibling PGD twins in this study is to be seen as incidental as the study group is too small to allow statistical analysis. An increased incidence of congenital anomalies in MZ twins, however, has been reported (Hall, 2003). It is clear that MZ twins are at high risk of perinatal morbidity and mortality in view of the low mean birthweight and low gestational age at birth, also observed in this study. A correlation between amnionicity and congenital anomalies or perinatal complications could not be established in this study. Conclusion Embryo biopsy for PGD does not cause an increase in the incidence of MZ twins. This information is useful in counselling patients undergoing PGD about the potential risks of the technique. Larger sample sizes are required to provide higher statistical power. Acknowledgements The authors thank the clinical, laboratory, technical, nursing and secretarial staff at the Centers for Reproductive Medicine and Medical Genetics at UZ Brussel.
5 No increase in monozygotic twinning with PGD 2949 Funding Fund for Scientific Research, Flanders, Belgium; Onderzoeksraad, Vrije Universiteit Brussel, Brussels, Belgium. References Abusheika N, Salha O, Shrama V, Brinsden P. Monozygotic twinning and IVF/ICSI treatment: a report of 11 cases and review of literature. Hum Reprod 2000;6: Alikani M, Noyes N, Cohen J, Rosenwaks Z. Monozygotic twinning in the human is associated with the zona pellucida architecture. Hum Reprod 1994;9: Alikani M, Cekleniak N, Walters E, Cohen J. Monozyotic twinning following assisted conception: an analysis of 81 consecutive cases. Hum Reprod 2003;18: Behr B, Fisch JD, Racowsky C, Miller K, Pool TB, Milki AA. Blastocyst-ET and monozygotic twinning. J Assist Reprod Genet 2000;17: Blickstein I. Estimation of iatrogenic monozygotic twinning rate following assisted reproduction: Pitfalls and caveats. Am J Obstet Gynecol 2005; 192: Blickstein I, Verhoeven HC, Keith LG. Zygotic splitting after assisted reproduction. N Engl J Med 1999;340: Bulmer MG. The Biology of Twinning in Man. Oxford: Clarendon Press, Burn J, Corney G. Zygosity determination and the types of twinning. In: MacGillivray I, Campbell DM, Thompson B (eds). Twinning and Twins. Chichester: John Wiley and Sons, 1988, Cassuto G, Chavrier M, Menezo Y. Cutlture conditions and not prolonged culture time are responsible for monozygotic twinning in human in vitro fertilization. Fertil Steril 2003;80: Chang HJ, Lee JR, Jee BC, Suh CS, Kim SH. Impact of blastocyst transfer on offspring sex ratio and the monozygotic twinning rate: a systematic review and meta-analysis. Fertil Steril 2009;91: Chitnis S, Derom C, Vlietinck R, Derom R, Monteiro J, Gregersen PK. X chromosome inactivation patterns confirm the late timing of monoamniotic MZ twinning. Am J Hum Genet 1999;65: Cohen J, Alikani M, Trowbridge J, Rosenwaks Z. Implantation enhancement by selective assisted hatching using zona drilling of human embryos with poor diagnosis. Hum Reprod 1992;7: Coonen E, Dumoulin JCM, Ramaekers FCS, Hopman AHN. Optimal preparation of preimplantation embryo interphase nuclei for analysis by fluorescent in situ hybridisation. Hum Reprod 1994;9: Costa ALE, Abdelmassih S, de Oliveira FG, Abdelmassih V, Abdelmassih R, Nagy Z, Balmaceda JP. Monozygotic twins and transfer at the blastocyst stage after ICSI. Hum Reprod 2001; 16: De Vos A, Van Steirteghem A. Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat Diagn 2001;21: Derom C, Vlietinck R, Derom R, van den Berghe H, Thiery M. Increased monozygotic twinning rate after ovulation induction. Lancet 1987; 1: Edwards RG, Mettler L, Walters DE. Identical twins and in vitro fertilization. J In Vitro Fert Embryo Transf 1986;3: Frankfurter D, Trimarchi J, Hackett R, Meng L, Keefe D. Monozygotic pregnancies from transfers of zona-free blastocysts. Fertil Steril 2004; 82: Hall JG. Twins and twinning. In: Rimoin DL, Connor JM, Pyeritz RE (eds). Emery and Rimoińs Principles and Practice of Medical Genetics, Vol. 1, 4th edn. New York: Churchill Livingstone, 2001, Hall JG. Twinning. Lancet 2003;362: ; Review. Hall JG. Pediatricians beware: the age of ARTs is upon us. J. Pediatr. 2005; 146: Healey SC, Kirk KM, Hyland VJ, Munns CF, Henders AK, Batch JA, Heath AC, Martin NG, Glass IA. Height discordance in monozygotic females is not attributable to discordant inactivation of X-linked stature determining genes. Twin Res 2001;4: Hershlag A, Paine T, Cooper GW, Scholl GM, Rawlinson K, Kvapil G. Monozygotic twinning associated with mechanical assisted hatching. Fertil Steril 1999;71: Jain JK, Boostanfar R, Slater CC, Francis MM, Paulson RJ. Monozygotic twins and triplets in association with blastocyst transfer. J Assist Reprod Genet 2004;21: Liebaers I, Sermon K, Staessen C, Joris H, Lissens W, Van Assche E, Nagy P, Bonduelle M, Vandervorst M, Devroey P et al. Clinical experience with preimplantation genetic diagnosis and intracytoplasmic sperm injection. Hum Reprod 1998;13: Machin GA. Why is it important to diagnose chorionicity and how do we do it? Best Pract Res Clin Obstet Gynaecol 2004;18: Malone FD. Monochorionic pregnancy where have we been? Where are we going? Am J Obstet Gynecol 2003;189: Menezo YJ, Sakkas D. Monozygotic twinning: is it related to apoptosis in the embryo? Hum Reprod 2002;17: Milki AA, Jun SH, Hinckley MD, Behr B, Giudice LC, Westphal LM. Incidence of monozygotic twinning with blastocyst transfer compared to cleavage-stage transfer. Fertil Steril 2003;79: Monteagudo A, Timor-Tritsch IE, Sharma S. Early and simple determination of chorionic and amniotic type in multifetal gestations in the first fourteen weeks by high-frequency transvaginal ultrasonoraphy. Am J Obstet Gynecol 1994;170: Saito H, Tsutsumi O, Noda Y, Ibuki Y, Hiroi M. Do assisted reproductive technologies have effects on the demography of monozygotic twinning? Fertil Steril 2000;74: Schachter M, Raziel A, Friedler S, Strassbuger D, Bern O, Ron-el R. Monozygotic twinning after assisted reproductive techniques: a phenomenon independent of micromanipulation. Hum Reprod 2001; 16: Schieve LA, Meikle SF, Peterson HB, Jeng G, Burnett NM, Wilcox LS. Does assisted hatching pose a risk for monozygotic twinning in pregnancies conceived through in vitro fertilization. Fertil Steril 2000; 74: Scott Sills E, Moomjy M, Zaninovic N, Veeck LL, McGee M, Palermo GD, Rosenwaks Z. Human zona pellucida micromanipulation and monozygotic twinning frequency after IVF. Hum Reprod 2000; 15: Sebire NJ, Snijders RJ, Hughes K, Sepulveda W, Nicolaides KH. The hidden mortality of monochorionic twin pregnancies. Br J Obstet Gynaecol 1997; 104: Sermon K. Current concepts in preimplantation genetic diagnosis (PGD): a molecular biologist s view. Hum Reprod Update 2002;8: Sermon K, De Rycke M. Single cell polymerase chain reaction for preimplantation genetic diagnosis: methods, strategies, and limitations. Methods Mol Med 2007;132: Sermon K, Seneca S, De Rycke M, Goossens V, Van de Velde H, De Vos A, Platteau P, Lissens W, Van Steirteghem A, Liebaers I. PGD in the lab for triplet repeat diseases-myotonic dystrophy, Huntington s disease and Fragile-X syndrome. Mol Cell Endocrinol 2001;183:S77 S85. Sermon K, Van Steirteghem A, Liebaers I. Preimplantation genetic diagnosis. Lancet 2004;363: Shapiro LR, Zemek L, Shulman MJ. Familial MZ twinning: an autosomal dominant form of MZ twinning with variable penetrance. In: Nance W, Allen G, Parisi P (eds). Twin Research: Biology and Epidemiology. New York: Alan R Liss, 1978,
6 2950 Verpoest et al. Staessen C, Van Assche E, Joris H, Bonduelle M, Vandervorst M, Liebaers I, Van Steirteghem A. Clinical experience of sex determination by fluorescent in-situ hybridization for preimplantation genetic diagnosis. Mol Hum Reprod 1999;5: Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, Devroey P, Liebaers I, Van Steirteghem A. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 2004; 19: Tarlatzis B, Qublan H, Sanopoulou T, Zepiridis L, Grimbizis B, Bontis J. Increase in the monozygotic twinning rate after intracytoplasmic sperm injection and blastocyst stage embryo transfer. Fertil Steril 2002; 77: Toledo M. Is there increased monozygotic twinning after assisted reproductive technology? Aust N Z J Obstet Gynaecol 2005;45: Van Landuyt L, De Vos A, Joris H, Verheyen G, Devroey P, Van Steirteghem A. Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure. Fertil Steril 2005;83: Van Landuyt L, Verheyen G, Tournaye H, Camus M, Devroey P, Van Steirteghem A. New Belgian embryo transfer policy leads to sharp decrease in multiple pregnancy rate. Reprod Biomed Online 2006;13: Vandervorst M, Liebaers I, Sermon K, Staessen C, De Vos A, Van de Velde H, Van Asche E, Joris H, Van Steirteghem A, Devroey P. Successful preimplantation genetic diagnosis is related to the number of available cumulus-oocyte complexes. Hum Reprod 1998;13: Wright V, Schieve LA, Vahratian A, Reynolds MA. Monozygotic twinning associated with day 5 embryo transfer in pregnancies conceived after IVF. Hum Reprod 2004;8: Submitted on March 23, 2009; resubmitted on June 18, 2009; accepted on July 6, 2009
Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer
Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer Evangelosa G. Papanikolaou, M.D., Ph.D., a,b Human Fatemi, M.D., Ph.D., a Christos
More informationRisk factors for monozygotic twinning in IVF: a multicenter, cohort study
Risk factors for monozygotic twinning in IVF: a multicenter, cohort study New England Fertility Society May 6 th, 2017. Denis A. Vaughan Nothing to disclose Disclosures Objectives Background on monozygotic
More informationTHE EFFECTS OF ART ON MZ TWINNING: MICROMANIPULATION & THE RISK OF MULTIPLE PREGNANCY
THE EFFECTS OF ART ON MZ TWINNING: MICROMANIPULATION & THE RISK OF MULTIPLE PREGNANCY Ramón Aurell, Itziar Belil, Anna Veiga & Pedro N. Barri. Obstetric, Gynecology & Reproductive Medicine Services. Institut
More informationShould we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer?
Human Reproduction Vol.19, No.11 pp. 2550 2554, 2004 Advance Access publication August 6, 2004 doi:10.1093/humrep/deh447 Should we advise patients undergoing IVF to start a cycle leading to a day 3 or
More informationCumulative reproductive outcome after preimplantation genetic diagnosis: a report on 1498 couples
Human Reproduction, Vol.24, No.11 pp. 2951 2959, 2009 Advanced Access publication on August 3, 2009 doi:10.1093/humrep/dep272 ORIGINAL ARTICLE Reproductive genetics Cumulative reproductive outcome after
More informationThe risk of monozygotic twins after assisted reproductive technology: a systematic review and meta-analysis
Human Reproduction Update, Vol.15, No.1 pp. 45 55, 2009 Advanced Access publication on October 15, 2008 doi:10.1093/humupd/dmn045 The risk of monozygotic twins after assisted reproductive technology: a
More informationPreimplantation genetic diagnosis: polar body and embryo biopsy
Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director
More informationAbstract. Introduction. Materials and methods. Patients and methods
RBMOnline - Vol 8. No 3. 344-348 Reproductive BioMedicine Online; www.rbmonline.com/article/1178 on web 20 January 2004 Article Cumulative live birth rates after transfer of cryopreserved ICSI embryos
More informationCommittee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler
Committee Paper Committee: Scientific and Clinical Advances Advisory Committee Meeting Date: 12 May 2009 Agenda Item: 4 Paper Number: SCAAC(05/09)01 Paper Title: ICSI guidance Author: Hannah Darby and
More informationPreimplantation Genetic Testing
Protocol Preimplantation Genetic Testing (40205) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization No Review Dates: 09/11, 09/12, 09/13 The following Protocol contains medical
More informationOriginal Policy Date
MP 2.04.77 Preimplantation Genetic Testing Medical Policy Section OB/Gyn/Reproduction Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to
More informationAn Update on PGD: Where we are today
An Update on PGD: Where we are today Joyce Harper UCL Centre for PG&D and CRGH Institute for Womens Health University College London Overview What is PGD/PGS How we do it Disadvantages and advantages Future
More informationPreimplantation Genetic Diagnosis (PGD) in Western Australia
Preimplantation Genetic Diagnosis (PGD) in Western Australia Human somatic cells have 46 chromosomes each, made up of the 23 chromosomes provided by the egg and the sperm cell from each parent. Each chromosome
More informationArticle Which patients with recurrent implantation failure after IVF benefit from PGD for aneuploidy screening?
RBMOnline - Vol 12. No 3. 2006 334-339 Reproductive BioMedicine Online; www.rbmonline.com/article/1947 on web 25 January 2006 Article Which patients with recurrent implantation failure after IVF benefit
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More informationS.Kahraman 1,4, M.Bahçe 2,H.Şamlı 3, N.İmirzalıoğlu 2, K.Yakısn 1, G.Cengiz 1 and E.Dönmez 1
Human Reproduction vol.15 no.9 pp.2003 2007, 2000 Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation
More informationPreimplantation genetic diagnosis for aneuploidy screening in women older than 37 years
Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years Peter Platteau, M.D., a Catherine Staessen, Ph.D., a,b An Michiels, M.Sc., b Andre Van Steirteghem, Ph.D., a Inge
More informationPatient selection criteria for blastocyst culture in IVF/ICSI treatment
J Assist Reprod Genet (2010) 27:555 560 DOI 10.1007/s10815-010-9457-9 ASSISTED REPRODUCTION Patient selection criteria for blastocyst culture in IVF/ICSI treatment M. Y. Thum & V. Wells & H. Abdalla Received:
More informationORIGINAL ARTICLE Reproductive genetics
Human Reproduction, Vol.24, No.2 pp. 470 476, 2009 Advanced Access publication on December 2, 2008 doi:10.1093/humrep/den402 ORIGINAL ARTICLE Reproductive genetics Two-year auxological and medical outcome
More informationIncidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients
Incidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients M. C. MAGLI,1 L. GIANAROLI,1,3 S. MUNNE,2 and A. P. FERRARETTI1 Submitted: December 29,
More informationIdentification of embryonic chromosomal abnormality using FISH-based preimplantaion genetic diagnosis
Ye et al. / J Zhejiang Univ SCI 2004 5(10):1249-1254 1249 Journal of Zhejiang University SCIENCE ISSN 1009-3095 http://www.zju.edu.cn/jzus E-mail: jzus@zju.edu.cn Identification of embryonic chromosomal
More informationProblem Challenge Need. Solution Innovation Invention
Problem Challenge Need Solution Innovation Invention Tubal Infertility In-vitro Fertilisation Steptoe and Edwards Birth after the reimplantation of a human embryo. Lancet 1978 Louise Brown, 25. Juli 1978
More informationPre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN
Pre-Implantation Genetic Diagnosis Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Our Clinical Vignette A young couple in the mid-to-late twenties presents to your clinic to discuss having children. The
More informationChromosomal Aneuploidy
The Many Advantages of Trophectoderm Biopsy Compared to Day 3 Biopsy for Pre- Implantation Genetic Screening (PGS) Mandy Katz-Jaffe, PhD Chromosomal Aneuploidy Trisomy 21 Fetus Aneuploidy is the most common
More informationDichorionic triplets following frozenthawed poor-stage embryo transfer: a report of two cases and a review
Yanaihara et al. Reproductive Biology and Endocrinology (2017) 15:80 DOI 10.1186/s12958-017-0302-1 REVIEW Open Access Dichorionic triplets following frozenthawed poor-stage embryo transfer: a report of
More informationPre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN
Pre-Implantation Genetic Diagnosis Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Our Clinical Vignette A young couple in the mid-to-late twenties presents to your clinic to discuss having children. The
More informationPreimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent
Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent PGT analysis is offered to patients that seek to identify a chromosomal abnormality in their embryos prior to initiating
More informationESHRE PGD Consortium data collection XIII: cycles from January to December 2010 with pregnancy follow-up to October 2011
Human Reproduction, Vol.30, No.8 pp. 1763 1789, 2015 Advanced Access publication on June 12, 2015 doi:10.1093/humrep/dev122 ESHRE PAGES ESHRE PGD Consortium data collection XIII: cycles from January to
More informationUnderstanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre
Understanding eggs, sperm and embryos Marta Jansa Perez Wolfson Fertility Centre What does embryology involve? Aims of the embryology laboratory Creation of a large number of embryos and supporting their
More informationMedical Policy Preimplantation Genetic Testing
Medical Policy Preimplantation Genetic Testing Document Number: 004 Commercial* and Connector/ Qualified Health Plans Authorization required X No notification or authorization Not covered * Not all commercial
More informationComparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement
Comparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement Wei-Hua Wang, Ph.D., Khalied Kaskar, M.S., Yuhong Ren, M.S., Jimmy Gill, M.D.,
More informationBlastocyst Morphology Holds Clues Concerning The Chromosomal Status of The Embryo
Original Article Blastocyst Morphology Holds Clues Concerning The Chromosomal Status of The Embryo Rita de Cassia Savio Figueira, M.Sc. 1, Amanda Souza Setti, B.Sc. 1,, Daniela Paes Almeida Ferreira Braga,
More informationTargeted qpcr. Debate on PGS Technology: Targeted vs. Whole genome approach. Discolsure Stake shareholder of GENETYX S.R.L
Antonio Capalbo, PhD Laboratory Director GENETYX, reproductive genetics laboratory, Italy PGT responsible GENERA centers for reproductive medicine, Italy Debate on PGS Technology: Targeted vs. Whole genome
More informationRisk of congenital anomalies in children born after frozen embryo transfer with and without vitrification
Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification Aila Tiitinen Professor, reproductive medicine Head of IVF unit Helsinki University The outline
More informationAssisted reproductive technology
Assisted reproductive technology FERTILITY AND STERILITY Copyright 1994 The American Fertility Society Vol. 62, No.4, October 1994 Printed on acid-free paper in U. S. A. Cryopreservation of supernumerary
More informationPGS & PGD. Preimplantation Genetic Screening Preimplantation Genetic Diagnosis
1 PGS & PGD Preimplantation Genetic Screening Preimplantation Genetic Diagnosis OUR MISSION OUR MISSION CooperGenomics unites pioneering leaders in reproductive genetics, Reprogenetics, Recombine, and
More informationArticle Pre-embryonic diagnosis for Sandhoff disease
RBMOnline - Vol 12. No 3. 2006 328-333 Reproductive BioMedicine Online; www.rbmonline.com/article/2100 on web 9 January 2006 Article Pre-embryonic diagnosis for Sandhoff disease Dr Anver Kuliev received
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationLouise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization
Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization IVF 1878 - first reported attempts at IVF 1959 - IVF births in rabbits in USA 1968
More informationMenstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
More informationIVF/ICSI twin pregnancies: risks and prevention
Human Reproduction Update Advance Access published August 25, 2005 Human Reproduction Update Page 1 of 19 doi:10.1093/humupd/dmi027 IVF/ICSI twin pregnancies: risks and prevention Anja Pinborg The Fertility
More informationArticles Impact of parental gonosomal mosaicism detected in peripheral blood on preimplantation embryos
RBMOnline - Vol 5. No 3. 306 312 Reproductive BioMedicine Online; www.rbmonline.com/article/699 on web 12 September Articles Impact of parental gonosomal mosaicism detected in peripheral blood on preimplantation
More informationSingle embryo transfer in preimplantation genetic diagnosis cycles for women <36 years does not reduce delivery rate
Human Reproduction pp. 1 5, 2007 Hum. Reprod. Advance Access published January 4, 2007 doi:10.1093/humrep/del470 Single embryo transfer in preimplantation genetic diagnosis cycles for women
More informationArticles Polar body-based preimplantation diagnosis for X-linked disorders
RBMOnline - Vol 4. No 1. 38 42 Reproductive BioMedicine Online; www.rbmonline.com/article/384 on web 20 November 2001 Articles Polar body-based preimplantation diagnosis for X-linked disorders Dr Yury
More informationArticles Follow-up of children born after assisted reproductive technologies
RBMOnline - Vol 5. No 3. 317 322 Reproductive BioMedicine Online; www.rbmonline.com/article/669 on web 9 August 2002 Articles Follow-up of children born after assisted reproductive technologies Dr Michael
More informationWHAT IS A PATIENT CARE ADVOCATE?
WHAT IS A PATIENT CARE ADVOCATE? Fertility treatments can be overwhelming. As a member, you have unlimited access to a dedicated Patient Care Advocate (PCA), who acts as your expert resource for discussing
More informationIncrease your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0)
Increase your chance of IVF Success PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0) What is PGT-A? PGT-A, or Preimplantation Genetic Testing for Aneuploidy (PGS 2.0), is a type of genomic
More informationIndications for chromosome screening Dagan Wells, PhD, FRCPath dagan.wells@obs-gyn.ox.ac.ukgyn.ox.ac.uk Chromosome imbalance (aneuploidy) Uncontroversial data The incidence of aneuploidy Aneuploidy is
More informationH.Van de Velde 1, Z.P.Nagy, H.Joris, A.De Vos and A.C.Van Steirteghem
Human Reproduction vol.12 no.10 pp.2246 2250, 1997 Effects of different hyaluronidase concentrations and mechanical procedures for cumulus cell removal on the outcome of intracytoplasmic sperm injection
More informationAbstract. Introduction. RBMOnline - Vol 10. No Reproductive BioMedicine Online; on web 4 February 2005
RBMOnline - Vol 10. No 4. 2005 436 441 Reproductive BioMedicine Online; www.rbmonline.com/article/1641 on web 4 February 2005 Ethics, legal, social, counselling Belgian legislation and the effect of elective
More informationApplication of OMICS technologies on Gamete and Embryo Selection
Application of OMICS technologies on Gamete and Embryo Selection Denny Sakkas, Ph.D. Scientific Director, Boston IVF Waltham, MA, USA THE FUTURE ROLE OF THE EMBRYOLOGIST WILL FOCUS ON PROVIDING OUR PATIENTS
More informationClosed blastocyst vitrification of biopsied embryos: evaluation of 100 consecutive warming cycles
Human Reproduction, Vol.0, No.0 pp. 1 7, 2010 doi:10.1093/humrep/deq338 Hum. Reprod. Advance Access published December 7, 2010 ORIGINAL ARTICLE Embryology Closed blastocyst vitrification of biopsied embryos:
More informationSociety for Assisted Reproductive Technology and American Society for Reproductive Medicine
FERTILITY AND STERILITY VOL. 74, NO. 4, OCTOBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. ASRM/SART REGISTRY
More informationPredictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older
Reprod Med Biol (2009) 8:145 149 DOI 10.1007/s12522-009-0023-z ORIGINAL ARTICLE Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older Akihisa
More informationSynchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome
Reproductive BioMedicine Online (2012) 24, 527 531 www.sciencedirect.com www.rbmonline.com ARTICLE Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationIVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman
IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major
More informationInfertility, infertility treatment and twinning: the Danish National Birth Cohort
Human Reproduction pp. 1 5, 2007 Hum. Reprod. Advance Access published January 4, 2007 doi:10.1093/humrep/del495 Infertility, infertility treatment and twinning: the Danish National Birth Cohort Jin Liang
More informationA BS TR AC T. n engl j med 357;1 july 5, 2007
The new england journal of medicine established in 1812 july 5, 2007 vol. 357 no. 1 In Vitro Fertilization with Preimplantation Genetic Screening Sebastiaan Mastenbroek, M.Sc., Moniek Twisk, M.D., Jannie
More informationPrenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters
Human Reproduction Vol.17, No.10 pp. 2600 2614, 2002 Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters Maryse Bonduelle 1,3, Elvire
More informationDoes blastomere biopsy in preimplantation genetic diagnosis affect early serum β-hcg levels?
ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2011;38(1):31-36 Does blastomere biopsy in preimplantation genetic diagnosis affect early serum β-hcg levels? Yeon Jean Cho 1, Jin Yeong
More informationOrganisation of the PGD Centre. Overview. Setting up a PGD centre
Organisation of the PGD Centre Joyce Harper Chair of the ESHRE PGD Consortium Overview Setting up a PGD Centre Organisation of the PGD Centre Preparation for clinical PGD Misdiagnosis Accreditation External
More informationINTRACYTOPLASMIC SPERM INJECTION
1 Background... 2 2 Male Factor Infertility... 2 3 ICSI... 3 4 Surgical sperm aspiration... 4 5 What is the chance of success?... 6 6 What are the risks?... 7 M Rajkhowa, October 2004 Authorised by V Kay
More informationReproductive Technology, Genetic Testing, and Gene Therapy
Michael Cummings Chapter 16 Reproductive Technology, Genetic Testing, and Gene Therapy David Reisman University of South Carolina 16.1 Infertility Is a Common Problem In the US, about 13% of all couples
More informationInternational Federation of Fertility Societies. Global Standards of Infertility Care
International Federation of Fertility Societies Global Standards of Infertility Care Standard 8 Reducing the incidence of multiple pregnancy following treatment for infertility Name Version number Author
More informationP.M.M.Kastrop 1, S.M.Weima, R.J.Van Kooij and E.R.Te Velde
Human Reproduction vol.14 no.1 pp.65 69, 1999 Comparison between intracytoplasmic sperm injection and in-vitro fertilization (IVF) with high insemination concentration after total fertilization failure
More informationPreimplantation Genetic Diagnosis (PGD) single gene disorders. A patient guide
Preimplantation Genetic Diagnosis (PGD) single gene disorders A patient guide Reproductive Genetic Innovations, LLC 2910 MacArthur Boulevard Northbrook, Illinois 60062 Phone: (847) 400-1515 Fax: (847)
More informationReproductive potential of a metaphase II oocyte retrieved after ovarian stimulation: an analysis of ICSI cycles
Human Reproduction, Vol.27, No.7 pp. 2030 2035, 2012 Advanced Access publication on May 2, 2012 doi:10.1093/humrep/des131 ORIGINAL ARTICLE Infertility Reproductive potential of a metaphase II oocyte retrieved
More informationIVF Michigan, Rochester Hills, Michigan, and Reproductive Genetics Institute, Chicago, Illinois
FERTILITY AND STERILITY VOL. 80, NO. 4, OCTOBER 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. CASE REPORTS Preimplantation
More informationEmbryo Selection after IVF
Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus
More informationPerinatal follow-up of children born after preimplantation genetic diagnosis between 1995 and 2014
Journal of Assisted Reproduction and Genetics (2018) 35:1995 2002 https://doi.org/10.1007/s10815-018-1286-2 ASSISTED REPRODUCTION TECHNOLOGIES Perinatal follow-up of children born after preimplantation
More informationCLINICAL RESULTS 2016
CLINICAL RESULTS 2016 RESULTS OF ASSISTED REPRODUCTIVE TREATMENTS CARRIED OUT ATTHEIVIGROUPDURING2016 In Vitro Fertilisation (IVF-ICSI) Ovum Donation (OVODON) Frozen Embryo Transfer PreimplantationGeneticDiagnosis
More informationDr Manuela Toledo - Procedures in ART -
Dr Manuela Toledo - Procedures in ART - Fertility Specialist MBBS FRANZCOG MMed CREI Specialities: IVF & infertility Fertility preservation Consulting Locations East Melbourne Planning a pregnancy - Folic
More informationIVF Health Risk 503,000 Hit in Google in 0.2 seconds
Assisted Reproductive Technologies and Perinatal Morbidity: Interrogating the Association Kurt Barnhart, M.D., MSCE. William Shippen Jr Professor of Obstetrics and Gynecology and Epidemiology Perelman
More informationPREIMPLANTATION GENETIC DIAGNOSIS
PREIMPLANTATION GENETIC DIAGNOSIS Peter Braude, Susan Pickering, Frances Flinter and Caroline Mackie Ogilvie Preimplantation genetic diagnosis (PGD) is an evolving technique that provides a practical alternative
More informationThe Jones Institute for Reproductive Medicine Founded on Science, Dedicated to Life
The Jones Institute for Reproductive Medicine Founded on Science, Dedicated to Life Assisted reproductive technologies: State-of-the-ART Sergio Oehninger, MD, PhD Professor and Vice-Chair, Dept. Ob/Gyn
More informationReport to the Director-General of Health on the Risks and Benefits Associated with Assisted Reproductive Technologies
Report to the Director-General of Health on the Risks and Benefits Associated with Assisted Reproductive Technologies The Advisory Group on Assisted Reproductive Technologies March 2005 Citation: AGART.
More informationINSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018
INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018 IVF-THE ULTIMATE GOAL FERTILISATION EMBRYO CLEAVAGE AND DEVELOPMENT POSITIVE HCG POSITIVE
More informationBirths following fertility treatment in the GUI infant cohort. Aisling Murray Growing Up in Ireland, ESRI
Births following fertility treatment in the GUI infant cohort www.growingup.ie Aisling Murray Growing Up in Ireland, ESRI About GUI Two cohorts: birth (9 months) and middle childhood (9 years) Current
More informationThyroid function after assisted reproductive technology in women free of thyroid disease
Thyroid function after assisted reproductive technology in women free of thyroid disease Kris Poppe, M.D., a Daniel Glinoer, M.D., Ph.D., b Herman Tournaye, M.D., Ph.D., c Johan Schiettecatte, c Patrick
More informationGenetics and Reproductive Options for SMA Families Annual SMA Conference Dallas, Texas Friday, June 15, 2017
Genetics and Reproductive Options for SMA Families 2018 Annual SMA Conference Dallas, Texas Friday, June 15, 2017 Part 1: SMA and Genetics Louise R Simard, PhD Part 2: SMA Carrier Screening Melissa Gibbons,
More informationInfertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations
Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should
More information24-Feb-15. Learning objectives. Family genetics: The future??? The traditional genetics. Genetics and reproduction in early 2015.
Learning objectives Family genetics: The future??? Peter Illingworth Medical Director IVFAustralia Understand how genetic problems may affect successful conception Consider the possible conditions and
More informationSNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation carrier and normal blastocysts
J Assist Reprod Genet (2016) 33:1115 1119 DOI 10.1007/s10815-016-0734-0 TECHNOLOGICAL INNOVATIONS SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation
More informationKaryotyping, congenital anomalies and follow-up of children after intracytoplasmic sperm injection with non-ejaculated sperm: a systematic review
Human Reproduction Update, Vol.16, No.1 pp. 12 19, 2010 Advanced Access publication on August 21, 2009 doi:10.1093/humupd/dmp030 Karyotyping, congenital anomalies and follow-up of children after intracytoplasmic
More informationBlastomere transplantation in human embryos may be a treatment for single gene diseases
FERTILITY AND STERILITY VOL. 81, NO. 4, APRIL 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Blastomere transplantation in
More informationBlastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2 3 embryo transfer cycles: a prospective, randomized study
FERTILITY AND STERILITY VOL. 81, NO. 3, MARCH 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Blastocyst-stage embryo transfer
More informationThe number of eight-cell embryos is a key determinant for selecting day 3 or day 5 transfer
FERTILITY AND STERILITY VOL. 73, NO. 3, MARCH 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. The number of eight-cell
More informationShould ICSI be implemented during IVF to all advanced-age patients with non-male factor subfertility?
Farhi et al. Reproductive Biology and Endocrinology (2019) 17:30 https://doi.org/10.1186/s12958-019-0474-y RESEARCH Open Access Should ICSI be implemented during IVF to all advanced-age patients with non-male
More informationAssisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE
Human Reproduction, Vol.1, No.1 pp. 1 21, 2009 doi:10.1093/humrep/dep035 Hum. Reprod. Advance Access published February 18, 2009 ORIGINAL ARTICLE ESHRE Assisted reproductive technology and intrauterine
More informationPuerto Rico Fertility Center
Puerto Rico Fertility Center General Information of the In-Vitro Fertilization Program Dr. Pedro J. Beauchamp First test-tube baby IN PUERTO RICO Dr. Pedro Beauchamp with Adlin Román in his arms. Paseo
More informationAssisted Reproductive Technology National Summary Report Belgium 2015
Assisted Reproductive Technology National Summary Report Belgium 2015 College van Geneesheren Reproductieve Geneeskunde Collège de Médecins Médecine de la Reproduction College of Physicians Reproductive
More informationDeliveries of normal healthy babies from embryos originating from oocytes showing the presence of smooth endoplasmic reticulum aggregates
Human Reproduction, Vol.28, No.8 pp. 2111 2117, 2013 Advanced Access publication on May 21, 2013 doi:10.1093/humrep/det241 ORIGINAL ARTICLE Embryology Deliveries of normal healthy babies from embryos originating
More informationHuman zona pellucida micromanipulation and monozygotic twinning frequency after IVF
Human Reproduction vol.15 no.4 pp.890 895, 2000 Human zona pellucida micromanipulation and monozygotic twinning frequency after IVF E.Scott Sills 1,3, Maureen Moomjy 1, Nikica Zaninovic 1, Lucinda L.Veeck
More informationOptimizing Fertility and Wellness After Cancer. Kat Lin, MD, MSCE
Optimizing Fertility and Wellness After Cancer Kat Lin, MD, MSCE University Reproductive Care University of Washington Nov. 6, 2010 Optimism in Numbers 5-year survival rate 78% for all childhood cancers
More informationIn Vitro Fertilization, Intracytoplasmic Sperm Injection Assisted Hatching Embryo Freezing
NAME (Patient): NAME (Partner): DOB: DOB: MEDICAL RECORD NUMBER: MEDICAL RECORD NUMBER: Informed Consent for Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection Assisted Hatching
More informationUnderstanding the Human Karyotype Colleen Jackson Cook, Ph.D.
Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. SUPPLEMENTAL READING Nussbaum, RL, McInnes, RR, and Willard HF (2007) Thompson and Thompson Genetics in Medicine, 7th edition. Saunders: Philadelphia.
More informationOverview. In Vitro Fertilization: a Success Story
Does IVF cause adverse perinatal outcomes? Paolo Rinaudo *, MD PhD Rebecca A. Jackson %, MD Departments of Ob/Gyn & *Center for Reproductive Sciences & % Epi/Biostats University of California, San Francisco
More information